Citation: Ss. Ehrmeyer et Rh. Laessig, APPLICATION OF THE DEPARTMENT-OF-HEALTH AND HUMAN-SERVICES PROPOSED WAIVED STATUS REQUIREMENTS FOR IN-VITRO DIAGNOSTIC TESTING DEVICES - CASE-STUDY, Clinical chemistry, 43(9), 1997, pp. 1610-1617
Citation: Rh. Laessig et al., A MODEST PROPOSAL - A QC PARADIGM USING ELECTRONIC CONTROLS TO MEET CLIA88 REQUIREMENTS, Clinical chemistry, 42(6), 1996, pp. 738-738
Authors:
OLAFSDOTTIR E
WESTGARD JO
EHRMEYER SS
FALLON KD
Citation: E. Olafsdottir et al., MATRIX EFFECTS AND THE PERFORMANCE AND SELECTION OF QUALITY-CONTROL PROCEDURES TO MONITOR PO2 MEASUREMENTS, Clinical chemistry, 42(3), 1996, pp. 392-396
Citation: Ss. Ehrmeyer et Rh. Laessig, REGULATORY REQUIREMENTS (CLIA-88, JCAHO, CAP) FOR DECENTRALIZED TESTING, American journal of clinical pathology, 104(4), 1995, pp. 40-49
Authors:
EHRMEYER SS
BURMEISTER BJ
LAESSIG RH
HASSEMER DJ
Citation: Ss. Ehrmeyer et al., LABORATORY PERFORMANCE IN A STATE PROFICIENCY TESTING PROGRAM - WHAT CAN A LABORATORIAN TAKE HOME, Journal of clinical immunoassay, 17(4), 1994, pp. 223-230